Royalty Report: Medical, Device, Therapeutic – Collection: 28761

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 8

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8

Primary Industries

  • Medical
  • Device
  • Therapeutic
  • Radiation
  • X-ray
  • Surgical
  • Cancer
  • Software
  • Environmental Control
  • Scientific & Technical Instruments

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 28761

License Grant
The Company has a License Agreement with the Licensor regarding the DRTS platform.
License Property
The technology is a laser targeting system or the Dual Radiation Targeting System (DRTS) to both reduce radiation exposure and improve accuracy of interventional procedures.

Their invention, called the DRTSâ„¢ Platform (Dual Radiation Targeting System), is a laser targeting system for fluoroscopically guided procedures. It allows the surgeon to use a fluoroscope to visualize and locate a deep structure, turn off the X-ray radiation, and still have accurate guidance and position information to complete the procedure. In addition to increasing surgical accuracy, the system significantly reduces time in the operating room, as well as radiation exposure for operating room personnel and patients.

IPSCIO Record ID: 204314

License Grant
Licensor grants a worldwide, exclusive license to use and sell X-Ray Systems in the Field.  Licensee desires to be the exclusive marketing and distribution entity for X-Ray Systems.
License Property
The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

The overall components of the system are  Catheter Body Subassembly,  X-Ray Tube, Control Device and Delivery Device.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

IPSCIO Record ID: 27532

License Grant
The parties desire to amend the Agreement in order to modify their arrangements with respect to the development of the X-Ray Systems.
License Property
X-Ray Systems is based on Photoelectron's patented technology. The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy.

Licensor is leveraging its core expertise in miniature x-ray technology into distinct markets including cancer treatment, intravascular care, industrial x-ray, and radiation dosimetry products.

The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

IPSCIO Record ID: 215206

License Grant
Licensor grants a worldwide right and license to manufacture and sell X-Ray Systems exclusively to Licensor for use in the Field.

Licensor grants a worldwide, non-exclusive license to manufacture, use and sell Delivery Devices outside the Field.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

License Property
The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

The overall components of the system are  Catheter Body Subassembly,  X-Ray Tube, Control Device and Delivery Device.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

Licensee is leveraging its core expertise in miniature x-ray technology into distinct markets including cancer treatment, intravascular care, industrial x-ray, and radiation dosimetry products.

IPSCIO Record ID: 375426

License Grant
The Licensee acquired certain intellectual property from an undisclosed Licensor to be used in the development of the ALLY Adaptive Cataract Treatment System.
License Property
ALLY Adaptive Cataract Treatment System is designed to combine our existing femtosecond laser technology with enhanced capabilities and a phacoemulsification system into a single unit and allow surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.
Field of Use
The rights acquired are for laser technology in a device used by medical surgeons in a cataract procedure.

IPSCIO Record ID: 476

License Grant
Licensor hereby grants an exclusive a royalty-bearing license, with the right to grant sublicenses under the Reliant Intellectual Property solely to make, have made, use, import, offer for sale and sell Products in the Field on a worldwide basis.
License Property
The technology involved includes CO2 laser accessories and scanners primarily for use in cosmetic and surgical applications.  U.S. Patent No. 5995265, 5786924, 5546214, 5420882, 5128509 and 5163936.
Field of Use
Field means use in surgical (including cosmetic and/or aesthetic) applications or veterinary applications.

IPSCIO Record ID: 253950

License Grant
Licensor, an university technology transfer organization, grants a first right of refusal to additional fields not included in the Licensed Field.
License Property
The current patent list includes and refers to Methods and Apparatus for Radiation Therapy, and, Radiation Therapy System with Constrained Rotational Freedom and Radiation Therapy System, and others.

UNITED STATES 5,317,616 METHOD AND APPARATUS FOR RADIATION THERAPY
UNITED STATES 08/071742 RADIATION THERAPY SYSTEM WITH CONSTRAINED ROTATIONAL FREEDOM
UNITED STATES 5,442,675 DYNAMIC COLLIMATOR FOR RADIATION THERAPY
UNITED STATES 5,394,452 VERIFICATION SYSTEM FOR RADIATION THERAPY
UNITED STATES 5,528,650 METHOD AND APPARATUS FOR RADIATION THERAPY
UNITED STATES 5,647,663 RADIATION TREATMENT PLANNING METHOD AND APPARATUS

Therapy Unit shall mean any item or unit capable on its own of producing radiation for the purposes of diagnostics, imaging, or therapy and that employs or is produced by the practice of an invention claimed in the Licensed Patents or would otherwise constitute infringement of any claims of the Licensed Patents.

Field of Use
The amendment clarifies that the Licensed Field explicitly excludes medical applications using Ions.

Licensee developed, market and sell advanced and versatile radiation therapy system for the treatment of a wide variety of cancers.

IPSCIO Record ID: 7475

License Grant
We have entered into an exclusive license agreement with the Israeli University.
License Property
The patent application 10/441934 filed May 20, 2003 underlying the license agreement covers a method, system and computer program for collecting and storing radiation and position data.
Field of Use
The rights granted apply to the software industry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.